RET C634R	Thyroid Gland Carcinoma	RET C634R	Thyroid Gland Carcinoma	ALW-II-41-27 Sensitive: D – Preclinical ALW-II-41-27 Sensitive : D	ALW-II-41-27 Sensitive: D – Preclinical ALW-II-41-27 Sensitive : D
RET M918T	Thyroid Gland Carcinoma	RET M918T	Thyroid Gland Carcinoma	ALW-II-41-27 Sensitive: D – Preclinical ALW-II-41-27 Sensitive : D	ALW-II-41-27 Sensitive: D – Preclinical ALW-II-41-27 Sensitive : D
EPHA2 expression + EGFR mutation	Non Small Cell Lung Cancer	EPHA2 expression + EGFR mutation	Non Small Cell Lung Cancer	BCY6033 Sensitive: D – Preclinical BCY6033 Sensitive : D	BCY6033 Sensitive: D – Preclinical BCY6033 Sensitive : D

EphA2 receptor antagonist

Associations(3)